Amber Implants Advances Pivotal European EXPAND Study of VCFix® Spinal System in Standalone Vertebral Reconstruction (opens in new tab)
Study evaluates VCFix® used with or without bone cement, expanding clinical experience with the company’s minimally invasive spine platform. The Hague, Netherlands, June 17, 2026 (GLOBE NEWSWIRE) — Amber Implants, a medical technology company redefining vertebral fracture treatment through minimally invasive reconstruction and targeted stabilization, today announced the advancement of its pivotal EXPAND clinical study […]
Read the original article